The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Theranostics: A treasured tailor for tomorrow
Open accessAbstract
Emerging as a targeted, safe, and efficient pharmacotherapy is the approach of theranostics, which focuses on patient-centered care. It is a combination of diagnosis and therapeutics. It provides a transition from conventional medicine to personalized medicine. It deals with the custom made treatment plan based on uniqueness of every individual thus resulting in right drug for the right patient at the right time. Genetics plays a significant role in theranostics. Theranostics provides a cost-effective specific successful treatment protocol. Pharmacogenetics, proteomics and biomarker profiling forms the backbone of theranostics. The role of theranostics is interestingly appreciated at multi levels with special consideration in oncology wherein nano formulations in the form of liposomes, dendrimers, polymeric nanoparticles, metallic nanoparticles, quantum dots and carbon nanotubes play a very important role. Thus, theranostics is a holistic transition from trial and error medicine to predictive, preventive and personalized medicine leading to improved quality care of pharmacotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Cited by
Synthesis, Characterization, and Applications of Metal Nanoparticles
Shnoudeh, A. J., Hamad, I., Abdo, R. W., Qadumii, L., Jaber, A. Y., Surchi, H. S., & Alkelany, S. Z. (2019) · Biomaterials and Bionanotechnology · doi:10.1016/b978-0-12-814427-5.00015-9 · Cited by 309
Current State of Breast Cancer Diagnosis, Treatment, and Theranostics
Bhushan, A., Gonsalves, A., & Menon, J. U. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050723 · Cited by 298
Metal nanoparticles: a theranostic nanotool against cancer
Sharma, H., Mishra, P. K., Talegaonkar, S., & Vaidya, B. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.05.009 · Cited by 294
Neurotheranostics as Personalized Medicines
Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124
A Review on Theranostics: An Approach to Targeted Diagnosis and Therapy
Shrivastava, S., Jain, S., Kumar, D., Soni, S. L., & Sharma, M. (2019) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v7i2.463 · Cited by 53
“theranostics is a holistic transition from trial and error medicine to predictive, preventive and personalized medicine leading to improved quality care of pharmacotherapy.(2) It uses specific biological pathways in the human body, to acquire diagnostic images and also to deliver a therapeutic dose of radiation to the…”
Background
Metadata
- Authors
- Jeelani, S., Jagat Reddy, R., Maheswaran, T., Asokan, G., Dany, A., & Anand, B.
- Venue
- Journal of Pharmacy And Bioallied Sciences
- Publisher
- Medknow
- Published
- 2014
- Volume
- 6
- Issue
- 5
- Pages
- 6
- ISSN
- 0975-7406 (ISSN-L)
- OpenAlex
- W2130127152
- Cited by
- 216
- References
- 1
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Theranostics: A treasured tailor for tomorrow. https://app.cochat.ai/papers/10.4103/0975-7406.137249
- The paper
- Jeelani, S., Jagat Reddy, R., Maheswaran, T., Asokan, G., Dany, A., & Anand, B. (2014). Theranostics: A treasured tailor for tomorrow. Journal of Pharmacy And Bioallied Sciences. https://doi.org/10.4103/0975-7406.137249
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.